Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.55 |
| ▸ | MAOB | P27338 | 1/20 | 0.55 |
| ▸ | LOX | P28300 | 1/20 | 0.55 |
| ▸ | CYP11B2 | P19099 | 13/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 10/20 | 0.50 |
| ▸ | CYP11B1 | P15538 | 9/20 | 0.50 |
| ▸ | SRD5A1 | P18405 | 2/20 | 0.40 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7572366 | 1.00 | MAOA (0.55) | MAOAMAOBLOXCYP11B2CYP19A1 | |
| SCHEMBL7572370 | 1.00 | MAOA (0.55) | MAOAMAOBLOXCYP11B2CYP19A1 | |
| SCHEMBL6757637 | 0.87 | MAOA (0.59) | MAOAMAOBLOXCYP11B2CYP19A1 | |
| SCHEMBL6757633 | 0.87 | MAOA (0.59) | MAOAMAOBLOXCYP11B2CYP19A1 | |
| SCHEMBL6757629 | 0.87 | MAOA (0.59) | MAOAMAOBLOXCYP11B2CYP19A1 | |
| SCHEMBL7564643 | 0.85 | CYP11B2 (0.51) | MAOAMAOBLOXCYP11B2CYP19A1 | |
| SCHEMBL7564639 | 0.85 | CYP11B2 (0.51) | MAOAMAOBLOXCYP11B2CYP19A1 | |
| SCHEMBL7564636 | 0.85 | CYP11B2 (0.51) | MAOAMAOBLOXCYP11B2CYP19A1 | |
| SCHEMBL7566749 | 0.84 | CYP11B2 (0.50) | MAOAMAOBLOXCYP11B2CYP19A1 | |
| SCHEMBL7566745 | 0.84 | CYP11B2 (0.50) | MAOAMAOBLOXCYP11B2CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6124284-A | REDUCED SIDE EFFECTS | GLAXO WELLCOME INC. (US) | 2000-09-26 | — | — | US | claimed |
| WO-1994026692-A1 | BICYCLIC AMIDE DERIVATIVES AND THEIR USE AS MUSCLE RELAXANTS | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-11-24 | — | — | WO | claimed |
| EP-0987248-B1 | Amide derivatives and their therapeutic use | WELLCOME FOUND (GB) | 2002-09-04 | — | — | EP | disclosed |
| EP-0699180-B1 | BICYCLIC AMIDE DERIVATIVES AND THEIR USE AS MUSCLE RELAXANTS | WELLCOME FOUND (GB) | 2000-11-22 | — | — | EP | disclosed |
| US-6124284-A | REDUCED SIDE EFFECTS | GLAXO WELLCOME INC. (US) | 2000-09-26 | — | — | US | disclosed |
| EP-0987248-A1 | Amide derivatives and their therapeutic use | THE WELLCOME FOUNDATION LIMITED (GB) | 2000-03-22 | — | — | EP | disclosed |
| US-5872118-A | RELAXATION OF SKELETAL MUSCLE IN SPASTIC, HYPERTONIC AND HYPERKINETIC CONDITIONS | GLAXO WELLCOME INC. (US) | 1999-02-16 | — | — | US | disclosed |
| EP-0699180-A1 | BICYCLIC AMIDE DERIVATIVES AND THEIR USE AS MUSCLE RELAXANTS | THE WELLCOME FOUNDATION LIMITED (GB) | 1996-03-06 | — | — | EP | disclosed |
| WO-1994026693-A1 | BICYCLIC AMIDE DERIVATIVES AND THEIR USE AS MUSCLE RELAXANTS | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-11-24 | — | — | WO | disclosed |
| WO-1994026692-A1 | BICYCLIC AMIDE DERIVATIVES AND THEIR USE AS MUSCLE RELAXANTS | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-11-24 | — | — | WO | disclosed |